Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment
NCT05719909 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-01-13
Summary
In a sample of patients already receiving esketamine treatment as part of their clinical care, this project seeks to test whether we can improve depression by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat depression more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Conditions
Interventions
- BEHAVIORAL
-
Cognitive Training
8 sessions of web-based cognitive training
- BEHAVIORAL
-
Sham Training
8 sessions of web-based sham training
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-14
- Primary Completion
- 2028-02-28
- Completion
- 2028-08-01
Countries
- United States
Study Locations
More Related Trials
-
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
NCT05910775 ·Status: TERMINATED ·Phase: NA
-
Brain Network Dynamics of Depression During Esketamine Treatment
NCT06012916 ·Status: COMPLETED
-
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
NCT00200902 ·Status: COMPLETED ·Phase: PHASE4
-
Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment
NCT00456014 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
NCT06476509 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
NCT00655057 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ketamine + Mindfulness for Depression
NCT05168735 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Imaging Predictors of Treatment Response in Depression
NCT00367341 ·Status: COMPLETED ·Phase: NA
-
Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
NCT00435695 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
NCT01640080 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
NCT00824044 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine Frequency Treatment for Major Depressive Disorder
NCT00646087 ·Status: WITHDRAWN ·Phase: PHASE4
-
Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
NCT02717052 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
NCT00733980 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
NCT05095792 ·Status: TERMINATED
-
Identifying Factors That Predict Antidepressant Treatment Response
NCT00360399 ·Status: COMPLETED ·Phase: NA
-
Positioning of Esketamine Treatment in the Real-world Management of Depression
NCT06103760 ·Status: RECRUITING ·Phase: PHASE4
-
Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
NCT01541475 ·Status: COMPLETED ·Phase: PHASE4
-
MBCT and Escitalopram for Treatment-Resistant Depression in Older Adults
NCT07077291 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD
NCT03131050 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
NCT02191397 ·Status: COMPLETED ·Phase: PHASE3
-
Advancing Personalized Antidepressant Treatment Using PET/MRI
NCT02623205 ·Status: COMPLETED ·Phase: PHASE4
-
Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response
NCT00456430 ·Status: COMPLETED ·Phase: PHASE4
-
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
NCT03434041 ·Status: COMPLETED ·Phase: PHASE3